טוען...
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities
Compared to other breast cancers, triple-negative breast cancer (TNBC) usually affects younger patients, is larger in size, of higher grade and is biologically more aggressive. To date, conventional cytotoxic chemotherapy remains the only available treatment for TNBC because it lacks expression of t...
שמור ב:
| הוצא לאור ב: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6316260/ https://ncbi.nlm.nih.gov/pubmed/30428522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph11040123 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|